Brief: Kaleido Biosciences Intends To Sell $30 Mln Of Common Shares In Offering

Kaleido Biosciences

01/06/2020 21:52

June 1 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF
COMMON
STOCK
    * KALEIDO BIOSCIENCES INC - INTENDS TO SELL $30 MILLION OF
SHARES
OF ITS COMMON STOCK IN OFFERING
    * KALEIDO BIOSCIENCES INC - INTENDS TO USE NET PROCEEDS FROM
OFFERING TO FUND ITS CONTINUED RESEARCH AND DEVELOPMENT
ACTIVITIES
    * KALEIDO BIOSCIENCES - CO'S CONTINUED RESEARCH AND
DEVELOPMENT
ACTIVITIES, INCLUDE ONGOING CLINICAL PROGRAM OF KB109 IN
PATIENTS WITH MILD-TO-MODERATE COVID-19

Source text for Eikon:  ID:nGNX36L9BX 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))